| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,198 |
3,033 |
$280K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,815 |
1,746 |
$110K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
671 |
560 |
$81K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
417 |
405 |
$53K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
274 |
261 |
$35K |
| 90461 |
|
520 |
482 |
$29K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
212 |
205 |
$29K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
167 |
165 |
$23K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
110 |
107 |
$15K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
407 |
357 |
$12K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
121 |
80 |
$11K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
49 |
49 |
$10K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
187 |
180 |
$7K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
62 |
62 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
33 |
33 |
$2K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
22 |
22 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
21 |
21 |
$2K |
| 83655 |
|
85 |
84 |
$2K |
| 85027 |
|
96 |
94 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
45 |
45 |
$1K |
| 99173 |
|
15 |
15 |
$1K |
| 96161 |
|
40 |
14 |
$734.53 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
28 |
28 |
$637.13 |
| 83718 |
|
31 |
31 |
$636.07 |
| 36415 |
Collection of venous blood by venipuncture |
55 |
54 |
$597.74 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
25 |
25 |
$436.37 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
15 |
15 |
$426.52 |
| 82465 |
|
31 |
31 |
$338.37 |
| 90686 |
|
428 |
224 |
$214.00 |
| 84460 |
|
13 |
13 |
$170.40 |
| 84450 |
|
13 |
13 |
$166.17 |
| 90656 |
|
16 |
16 |
$8.00 |